PSYBF PsyBio Therapeutics Corp

USD 0.01 0.00 0
Icon

PsyBio Therapeutics Corp (PSYBF) Stock Analysis and Price Targets

COMMON STOCK | Biotechnology | OTC
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.01

0.00 (0.00)%

USD 0.94M

3.03K

N/A

N/A

Icon

PSYBF

PsyBio Therapeutics Corp (USD)
COMMON STOCK | OTC
USD 0.01
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 0.94M

N/A

USD 0.01

PsyBio Therapeutics Corp (PSYBF) Stock Forecast

N/A

Based on the PsyBio Therapeutics Corp stock forecast from 0 analysts, the average analyst target price for PsyBio Therapeutics Corp is not available over the next 12 months. PsyBio Therapeutics Corp’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of PsyBio Therapeutics Corp is Bearish, which is based on 1 positive signals and 7 negative signals. At the last closing, PsyBio Therapeutics Corp’s stock price was USD 0.01. PsyBio Therapeutics Corp’s stock price has changed by -3.39% over the past week, -6.56% over the past month and -87.33% over the last year.

No recent analyst target price found for PsyBio Therapeutics Corp
No recent average analyst rating found for PsyBio Therapeutics Corp

Company Overview PsyBio Therapeutics Corp

PsyBio Therapeutics Corp., a biotechnology company, engages in the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. PsyBio Therapeutics Corp. was formerly known as...Read More

https://www.psybiolife.com

1624 Washington Street, Denver, CO, United States, 80203

0

December

USD

USA

Adjusted Closing Price for PsyBio Therapeutics Corp (PSYBF)

Loading...

Unadjusted Closing Price for PsyBio Therapeutics Corp (PSYBF)

Loading...

Share Trading Volume for PsyBio Therapeutics Corp Shares

Loading...

Compare Performance of PsyBio Therapeutics Corp Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PSYBF

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To PsyBio Therapeutics Corp (Sector: Biotechnology )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
NONOF
Novo Nordisk A/S 0.00 (0.00%) USD456.53B 41.43 4.67

ETFs Containing PSYBF

Symbol Name PSYBF's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About PsyBio Therapeutics Corp (PSYBF) Stock

Stock Target Advisor's fundamental analysis for PsyBio Therapeutics Corp's stock is Bearish.

Unfortunately we do not have enough data on PSYBF's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on PSYBF's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on PSYBF's stock to indicate if its overvalued.

The last closing price of PSYBF's stock was USD 0.01.

The most recent market capitalization for PSYBF is USD 0.94M.

Unfortunately we do not have enough analyst data on PSYBF's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains PsyBio Therapeutics Corp's stock.

As per our most recent records PsyBio Therapeutics Corp has 0 Employees.

PsyBio Therapeutics Corp's registered address is 1624 Washington Street, Denver, CO, United States, 80203. You can get more information about it from PsyBio Therapeutics Corp's website at https://www.psybiolife.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...